MEDI0382, a GLP-1 and glucagon receptor dual agonist, in obese or overweight patients with type 2 diabetes: a randomised, controlled, double-blind, ascending dose and phase 2a study
Ambery P, Parker VE, Stumvoll M, et al.
The Lancet. Pub. online 22 June 2018.
Leggi